Moderna

Most Recent

  • A doctor with Pfizer's COVID-19 vaccine
    Healthcare

    Pfizer's Omicron Vaccine Should Be Available in March—Too Late?

    Pfizer and Moderna are both working on a vaccine for the omicron variant of the COVID-19 virus. When will the vaccines be available? Will they be too late?
    By Mohit Oberoi, CFA
  • Blood sample testing positive for the omicron variant
    News

    Which Vaccines Are Effective Against Omicron? Pfizer and Moderna

    As the omicron variant of the COVID-19 virus spreads across globe, people want to know more about the vaccines. Which vaccines are effective against omicron?
    By Anuradha Garg
  • Moderna scientists in a lab
    Healthcare

    Is It Time to Sell Moderna (MRNA) Stock and Book Profits?

    On Nov. 5, Moderna stock fell 17 percent after a disappointing quarterly report. Is MRNA stock a buy or sell now based on its forecast?
    By Ambrish Shah
  • Person getting a COVID-19 vaccine
    Healthcare

    When Will the Moderna Booster Be Available and Who Is Eligible?

    When will the Moderna booster be available and who's eligible? Will people be able to mix and match COVID-19 vaccines?
    By Ruchi Gupta
  • Moderna COVID-19 vaccine vile
    News

    Will the FDA Approve the Moderna COVID-19 Booster This Week?

    Some people have gotten the Pfizer booster shot for the COVID-19 vaccine. When will Moderna's booster get FDA approval?
    By Rachel Curry
  • Girl getting a COVID-19 vaccine
    News

    When Will Moderna's COVID-19 Vaccine Be Approved for Kids?

    Moderna submitted a request in June for emergency use authorization of its two-shot COVID-19 vaccine for children aged 12–17. The FDA hasn’t given its approval yet.
    By Danielle Letenyei
  • COVID-19 vaccine
    Healthcare

    When Will the FDA Fully Approve Moderna's COVID-19 Vaccine?

    Investors want to know when the FDA will fully approve Moderna’s COVID-19 vaccine. FDA approval could fuel sales. Here's what investors can expect.
    By Ruchi Gupta
  • A hand holds a phial of Moderna's COVID-19 vaccine
    Healthcare

    Moderna Has Not Got FDA Approval Yet, but Might Get It Soon

    Pfizer-BioNTech vaccine became the first vaccine to be fully approved for COVID-19 by the FDA. Moderna’s vaccine is still awaiting FDA approval, but why?
    By Anuradha Garg
  • Moderna
    Healthcare

    Vaccine Maker Moderna Looks To Be Next To Receive the FDA’s Full Approval

    Pfizer announced its approval by the FDA this week for its COVID-19 vaccine. Moderna is likely still weeks away from receiving full approval.
    By Kathryn Underwood
  • Moderna employees using a computer
    Healthcare

    Moderna Stock Falls, Could Go Back Up Amid Pumping From WallStreetbets

    Moderna stock has come off its highs. Why is the stock falling and will it go back up on pumping from Reddit forum WallStreetBets?
    By Ambrish Shah
  • Moderna scientists
    Healthcare

    Moderna Stock (MRNA) Could Keep Delivering Value for Years

    Moderna stock has tripled this year. After its price surge, investors want to know Moderna's (MRNA) stock forecast for 2025. Does it look promising?
    By Anuradha Garg
  • Vials of the Moderna COVID-19 vaccine
    Healthcare

    Moderna Is a Good Stock to Buy Amid Israel Supply Agreement

    Moderna shares are up in the short term, but excitement over the stock's longevity could last much longer. Is Moderna stock a good buy?
    By Rachel Curry
  • Stéphane Bancel at Moderna's ribbon-cutting ceremony
    Healthcare

    Did Moderna CEO Stéphane Bancel Take the Vaccine Himself?

    Making a vaccine is one thing. Did the CEO of Moderna take the vaccine himself?
    By Rachel Curry
  • How Does the Moderna COVID-19 Vaccine Work?
    Healthcare

    How Does the Moderna COVID-19 Vaccine Work?

    How does Moderna's coronavirus vaccine work and how safe and effective will it be?
    By Kathryn Underwood
  • Moderna
    Healthcare

    Moderna’s COVID-19 Vaccine — All You Need to Know

    Moderna, a U.S. biotechnology company, announced the trial results for its COVID-19 vaccine. How effective is the vaccine?
    By Anuradha Garg
  • Moderna
    Healthcare

    Who Owns Moderna?

    Moderna, a biopharmaceutical company, has a coronavirus vaccine with initial trial results that show 94.5 percent effectiveness.
    By Kathryn Underwood
  • Why is Moderna Stock Dropping
    Healthcare

    Should You Buy the Dip in Moderna Stock?

    Moderna stock has fallen by about 30 percent in the previous month. Should you buy the dip in Moderna stock?
    By Ambrish Shah
  • Moderna
    News

    How the Moderna Vaccine Study Made Stocks Rise

    Moderna just released a vaccine report that shows a COVID-19 vaccine could generate antibodies in older adults. Here's what to know about the resulting Moderna stock price increase.
    By Rachel Curry
  • Moderna
    Healthcare

    Moderna Stock Soars, COVID-19 Vaccine Looks Promising

    Moderna (NASDAQ:MRNA) stock surged 16% in after-market trading hours on Tuesday following news of positive results related to its COVID-19 vaccine.

    By Sirisha Bhogaraju
  • Moderna
    Healthcare

    Moderna Stock Rises on Coronavirus Vaccine Deal

    Moderna stock rose after the company reached a deal with the federal government to sell 100 million doses of its coronavirus vaccine.
    By Ambrish Shah
  • Moderna
    Healthcare

    Moderna Will Join Nasdaq 100, Jefferies Assigns ‘Buy’ Rating

    Moderna will become a component of the NASDAQ 100 Index beginning on July 20. The stock will replace the CoStar Group in the NASDAQ-100.

    By Sirisha Bhogaraju
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.